Increasing Protein Intake May Help Prevent Muscle Loss in Patients Using Anti-Obesity Medication
New research indicates that increasing dietary protein may help prevent muscle loss in patients taking the anti-obesity drug semaglutide, especially in older adults and women. Preserving muscle mass is vital for metabolic health and improving treatment outcomes.
Recent research presented at ENDO 2025, the annual meeting of the Endocrine Society, highlights the potential benefits of higher dietary protein for individuals taking the weight-loss drug semaglutide. This medication, part of the GLP-1 receptor agonists, is effective in promoting weight reduction but is associated with muscle loss, which can adversely impact metabolism, bone health, and overall well-being.
A study involving 40 adults with obesity over three months found that those on semaglutide lost more weight compared to participants in a diet and lifestyle program called Healthy Habits for Life. While the percentage of lean mass lost was similar between both groups, factors such as older age, female gender, and lower protein consumption were linked to greater muscle loss in the semaglutide group. Importantly, increased muscle loss was associated with less improvement in blood sugar control, as measured by HbA1c levels.
The findings suggest that older adults and women might be more vulnerable to muscle loss during semaglutide treatment, but adequate protein intake could serve as a protective factor. Maintaining muscle mass is crucial since it supports proper blood sugar regulation and bone strength, helping to prevent frailty and insulin resistance in people undergoing weight-loss therapy.
Experts emphasize the need for further research to optimize fat loss strategies that preserve muscle during the use of GLP-1 medications. Their goal is to enhance the effectiveness of obesity treatments while minimizing unwanted side effects like muscle wasting.
Source: https://medicalxpress.com/news/2025-07-consuming-protein-patients-anti-obesity.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Revolutionary mRNA Vaccine Technology Developed to Combat Antibiotic-Resistant Bacteria
Researchers have adapted COVID-19 vaccine technology to create the first effective mRNA vaccine against antibiotic-resistant bacteria, showing promising results in animal models. This breakthrough paves the way for new bacterial vaccines using mRNA platforms.
Continued Use of Antiseizure Medications During Pregnancy Despite Risks
A recent study highlights the ongoing use of antiseizure medications during pregnancy, with some drugs posing known or uncertain risks to fetal development. The research calls for better management and awareness, especially among socioeconomically disadvantaged populations.
Reevaluating Schizophrenia Treatment: Modern Approaches to Clozapine Monitoring
New international guidelines are transforming how clinicians monitor and manage clozapine treatment in schizophrenia, aiming to enhance safety, reduce unnecessary barriers, and improve patient outcomes.
The Risks of Chemotherapy Enzyme Deficiency and the Importance of Genetic Testing
A tragic case underscores the vital importance of genetic testing before chemotherapy to prevent fatal toxicity caused by enzyme deficiencies. Learn why personalized medicine is crucial in cancer treatment.